Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2025
The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHSMatthew Walton, Nyanar Jasmine Deng, Mark Corbett, et al.
Health Technology Assessment (Winchester, England)|January 30, 2025
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathyRobert Hodgson, Matthew Walton, Helen Fulbright, et al.
International Journal of Cancer|December 10, 2023
A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: The REFoRMS-SR projectConnor Evans, Lucy Shepherd, Gemma Bryan, et al.
Health Technology Assessment (Winchester, England)|December 27, 2023
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysisRos Wade, Emily South, Sumayya Anwer, et al.
Journal of Affective Disorders|July 22, 2024
Collaborative care for common mental disorders in low- and middle-income countries: A systematic review and meta-analysisMehreen Riaz Faisal, Fakiha Tus Salam, Aishwarya Lakshmi Vidyasagaran, et al.
Health Technology Assessment (Winchester, England)|May 10, 2025
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysisMark Simmonds, Matthew Walton, Rob Hodgson, et al.
Health Technology Assessment (Winchester, England)|December 14, 2024
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysisMark Simmonds, Alexis Llewellyn, Ruth Walker, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2024
Anti-Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness AnalysisMatthew Walton, Laura Bojke, Mark Simmonds, et al.
Pageof 4